rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1994-7-26
|
pubmed:abstractText |
To aid in the design of an improved 99mTc-labeled renal agent, several new [99mTcO(MAG3)]2- analogs were synthesized to determine the effects of varying the position and chemical form of the terminal charged group on renal clearance.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1198-205
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8014683-Animals,
pubmed-meshheading:8014683-Biological Transport,
pubmed-meshheading:8014683-Chromatography, High Pressure Liquid,
pubmed-meshheading:8014683-Kidney Tubules,
pubmed-meshheading:8014683-Models, Chemical,
pubmed-meshheading:8014683-Rats,
pubmed-meshheading:8014683-Rats, Sprague-Dawley,
pubmed-meshheading:8014683-Technetium Tc 99m Mertiatide
|
pubmed:year |
1994
|
pubmed:articleTitle |
Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport.
|
pubmed:affiliation |
Department of Radiology, Emory University, Atlanta, Georgia.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|